These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3040166)

  • 1. Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects.
    Delay-Goyet P; Zajac JM; Javoy-Agid F; Agid Y; Roques BP
    Brain Res; 1987 Jun; 414(1):8-14. PubMed ID: 3040166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
    Delay-Goyet P; Roques BP; Zajac JM
    Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dog cerebral cortex contains mu-, delta- and kappa-opioid receptors at different densities: apparent lack of evidence for subtypes of the kappa-receptor using selective radioligands.
    Sharif NA; Durie E; Michel AD; Whiting RL
    Brain Res; 1990 Feb; 510(1):108-14. PubMed ID: 2157522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain.
    Mansour A; Khachaturian H; Lewis ME; Akil H; Watson SJ
    J Neurosci; 1987 Aug; 7(8):2445-64. PubMed ID: 3039080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
    Wang XJ; Han JS
    J Neurochem; 1990 Oct; 55(4):1379-82. PubMed ID: 2168937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy.
    Delay-Goyet P; Ruiz-Gayo M; Baamonde A; Gacel G; Morgat JL; Roques BP
    Pharmacol Biochem Behav; 1991 Jan; 38(1):155-62. PubMed ID: 1850135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential properties of mu and delta opiate binding sites studied with highly selective ligands.
    Zajac JM; Roques BP
    Life Sci; 1983; 33 Suppl 1():155-8. PubMed ID: 6319853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity states of rat brain opioid receptors in different tissue preparations.
    Zajac JM; Bigeard A; Delay-Goyet P; Roques BP
    J Neurochem; 1990 Mar; 54(3):992-9. PubMed ID: 2154555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors.
    Gacel G; Daugé V; Breuzé P; Delay-Goyet P; Roques BP
    J Med Chem; 1988 Oct; 31(10):1891-7. PubMed ID: 2845081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients.
    Fernandez A; de Ceballos ML; Jenner P; Marsden CD
    Neuroscience; 1994 Jul; 61(1):73-9. PubMed ID: 7969897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
    Werling LL; McMahon PN; Cox BM
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of selective mu- and delta-opioid peptides on kindled amygdaloid seizures in rats.
    Böhme GA; Stutzmann JM; Roques BP; Blanchard JC
    Neurosci Lett; 1987 Feb; 74(2):227-31. PubMed ID: 3033553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL; Brown SR; Puttfarcken P; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain.
    Waksman G; Hamel E; Fournié-Zaluski MC; Roques BP
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1523-7. PubMed ID: 3006054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu-opioid receptor in the 7315c tumor cell.
    Tocque B; Jacobson AE; Rice KC; Frey EA
    Eur J Pharmacol; 1987 Nov; 143(1):127-30. PubMed ID: 2826184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.